参考文献/References:
[1] Sen-Chowdhry S,Syrris P,Prasad SK,et al. Left-dominant arrhythmogenic cardiomyopathy:an under-recognized clinical entity[J]. J Am Coll Cardiol,2008,52(25):2175-2187.
[2] He J,Xu J,Li G,et al. Arrhythmogenic left ventricular cardiomyopathy:a clinical and CMR study[J]. Sci Rep,2020,10(1):533.
[3] Good JM,Fellmann F,Bhuiyan ZA,et al. ACTN2 variant associated with a cardiac phenotype suggestive of left-dominant arrhythmogenic cardiomyopathy[J]. HeartRhythm Case Rep,2019,6(1):15-19.
[4] Chakraborty P,Isser HS,Arava S,et al. Incessant left ventricular tachycardia of unusual etiology[J]. Indian pacing and electrophysiology journal,2016,16(3):104-106.
[5] Feliu E,Moscicki R,Carrillo L,et al. Importance of cardiac magnetic resonance findings in the diagnosis of left dominant arrythmogenic cardiomyopathy[J]. Rev Esp Cardiol (Engl Ed),2020:S1885-5857(19)30424-4.
[6] Akdis D,Brunckhorst C,Duru F,et al. Arrhythmogenic cardiomyopathy:electrical and structural phenotypes[J]. Arrhythm Electrophysiol Rev,2016,5(2):90-101.
[7] Sen-Chowdhry S,Syrris P,Ward D,et al. Clinical and genetic characterization of families with arrhythmogenic right ventricular dysplasia/cardiomyopathy provides novel insights into patterns of disease expression[J]. Circulation,2007,115(13):1710-1720.
[8] Bennett RG,Haqqani HM,Berruezo A,et al. Arrhythmogenic cardiomyopathy in 2018-2019:ARVC/ALVC or both?[J]. Heart Lung Circulation,2019,28(1):164-177.
[9] Tong LJ,Flach EJ,Sheppard MN,et al. Fatal arrhythmogenic right ventricular cardiomyopathy in 2 related subadult chimpanzees (Pan troglodytes) [J]. Vet Pathol ,2014,51(4):858-867.
[10] Sen-Chowdhry S,Morgan RD,Chambers JC,et al. Arrhythmogenic cardiomyopathy:etiology,diagnosis,and treatment[J]. Annu Rev Med,2010,61:233-253.
[11] 刘璇,惠汝太. 致心律失常性右室心肌病的研究进展[J]. 中国分子心脏病学杂志,2010,11(3):180-183.
[12] Corrado D,Link MS,Calkins H. Arrhythmogenic right ventricular cardiomyopathy[J]. N Engl J Med,2017,376(1):61-72.
[13] 王立群. 2019 HRS关于致心律失常性心肌病评估、危险分层及管理专家共识[J]. 临床心电学杂志,2019,28(4):241-269.
[14] Sen-Chowdhry S,Syrris P,McKenna WJ. Role of genetic analysis in the management of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy[J]. J Am Coll Cardiol,2007,50(19):1813-1821.
[15] Bauce B,Basso C,Rampazzo A,et al. Clinical profile of four families with arrhythmogenic right ventricular cardiomyopathy caused by dominant desmoplakin mutations[J]. Eur Heart J,2005,26(16):1666-1675.
[16] Corrado D,Wichter T,Link MS,et al. Treatment of arrhythmogenic right ventricular cardiomyopathy/dysplasia:an international task force consensus statement[J]. Circulation,2015,132(5):441-453.
[17] Bermúdez-Jiménez FJ,Carriel V,Brodehl A,et al. Novel desmin mutation p.Glu401Asp impairs filament formation,disrupts cell membrane integrity,and causes severe arrhythmogenic left ventricular cardiomyopathy/dysplasia[J]. Circulation,2018,137(15):1595-1610.
[18] di Bella G,Carerj S,Coglitore S. Left dominant arrhythmogenic cardiomyopathy a new clinical entity without a typical substrate of myocardial damage[J]. J Am Coll Cardiol,2009,53(17):1570-1571.
[19] Zegkos T,Panagiotidis T,Parcharidou D,et al. Emerging concepts in arrhythmogenic dilated cardiomyopathy[J]. Heart Fail Rev ,2020,Feb 13. DOI:10.1007/s10741-020-09933-z.
[20] Schulze-Bahr E,Klaassen S,Abdul-Khaliq H,et al. Molecular diagnosis for cardiovascular diseases[J]. Dtsch Med Wochenschr,2015,140(20):1538.
[21] Augusto JB,Eiros R,Nakou E,et al. Dilated cardiomyopathy and arrhythmogenic left ventricular cardiomyopathy:a comprehensive genotype-imaging phenotype study[J]. Eur Heart J Cardiovasc Imaging,2020,21(3):326-336.
[22] Hodgkinson KA,Connors SP,Merner N,et al. The natural history of a genetic subtype of arrhythmogenic right ventricular cardiomyopathy caused by a p.S358L mutation in TMEM43[J]. Clin Genet,2013,83(4):321-331.
[23] Towbin JA,McKenna WJ,Aerams DJ,et al. 2019 HRS expert consensus statement on evaluation,risk stratification,and management of arrhythmogenic cardiomyopathy[J]. Heart Rhythm,2019,16(11):e301-e372.
[24] Waki H,Eguchi K,Toriumi S,et al. Isolated cardiac sarcoidosis mimicking arrhythmogenic right ventricular cardiomyopathy[J]. Intern Med,2018,57(6):835-839.
[25] de Lazzari M,Zorzi A,Cipriani A,et al. Relationship between electrocardiographic findings and cardiac magnetic resonance phenotypes in arrhythmogenic cardiomyopathy[J]. J Am Heart Assoc,2018,7(22):e009855.
[26] Arnous S,Syrris P,Sen-Chowdhry S,et al. Genetics of dilated cardiomyopathy:risk of conduction defects and sudden cardiac death[J]. Card Electrophysiol Clin,2010,2(4):599-609.
[27] Conte E,Mushtaq S,Pontone G,et al. Left-dominant arrhythmogenic cardiomyopathy diagnosed at cardiac CT[J]. J Cardiovasc Comput Tomogr,2020,14(5):e7-e8.
[28] Tandri H,Saranathan M,Rodriguez ER,et al. Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging[J]. J Am Coll Cardiol,2005,45(1):98-103.
[29] Mirmomen SM,Bradley AJ,Arai A E,et al. Arrhythmogenic left ventricular cardiomyopathy[J]. BJR Case Rep,2020,6(1):20190079.
[30] Busardò FP,Cappato R,Dovidio C,et al. Fatal left-dominant arrhythmogenic cardiomyopathy involving a 25-year old professional football player:could it have been prevented?[J]. Int J Cardiol,2014,174(2):423-425.
[31] Santangeli P,Zado ES,Supple GE,et al. Long-term outcome with catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy[J].Circ Arrhythm Electrophysiol,2015,8(6):1413-1421.
[32] Dalal D,Jain R,Tandri H,et al. Long-term efficacy of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy[J]. J Am Coll Cardiol,2007,50(5):432-440.
[33] Izquierdo M,Sánchez-Gómez JM,Ferrero de Loma-Osorio A,et al. Endo-epicardial versus only-endocardial ablation as a first line strategy for the treatment of ventricular tachycardia in patients with ischemic heart disease[J]. Circ Arrhythm Electrophysiol,2015,8(4):882-889.
[34] Cardoso R,Assis FR,Davila A. Endo-epicardial vs endocardial-only catheter ablation of ventricular tachycardia:a meta-analysis[J]. J Cardiovasc Electrophysiol,2019,30(9):1537-1548.
[35] Havranek S,Palecek T,Kovarnik T,et al. Arrhythmogenic substrate at the interventricular septum as a target site for radiofrequency catheter ablation of recurrent ventricular tachycardia in left dominant arrhythmogenic cardiomyopathy[J]. BMC Cardiovasc Disord ,2015,15:18.
[36] Mou L,Chen F,Dai Y,et al. Potential alternative approaches to xenotransplantation[J]. Int J Surg,2015,23(Pt B):322-326.
[37] Sanchez JE,Takatana H,Ando M,et al. Outcomes of bridge to cardiac retransplantation in the contemporary mechanical circulatory support era[J]. J Thorac Cardiovasc Surg,2019,158(1):171-181.
相似文献/References:
[1]唐欣 罗素新.心房颤动合并 射血分数保留的心力衰竭的研究进展[J].心血管病学进展,2019,(5):753.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.022]
TANG Xin,LUO Suxin.Atrial Fibrillation and Heart Failure with Preserved Ejection Fraction[J].Advances in Cardiovascular Diseases,2019,(4):753.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.022]
[2]黄巧娟 周晓莉.冠状动脉慢血流现象的研究进展[J].心血管病学进展,2020,(2):163.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.016]
HUANG QiaojuanZHOU Xiaoli.Coronary Slow Flow Phenomenon[J].Advances in Cardiovascular Diseases,2020,(4):163.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.016]
[3]朱珊英,朱国斌.肺动脉高压发病机制新进展[J].心血管病学进展,2020,(3):292.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.019]
ZHU Shanying,ZHU Guobin.Pathogenesis of Pulmonary Hypertension[J].Advances in Cardiovascular Diseases,2020,(4):292.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.019]
[4]郭辅定 殷铭 赖燕秋 江洪.蒽环类药物相关心血管疾病与自主神经调控展望[J].心血管病学进展,2021,(3):248.[doi:10.16806/j.cnki.issn.1004-3934.20 21.03.014]
GUO Fuding,YIN Ming,LAI Yanqiu,et al.Anthracycline-induced Cardiovascular Diseases and Autonomic Nervous Regulation[J].Advances in Cardiovascular Diseases,2021,(4):248.[doi:10.16806/j.cnki.issn.1004-3934.20 21.03.014]
[5]韩嘉明 高中山 马玉兰.不适当窦性心动过速的研究进展[J].心血管病学进展,2022,(3):253.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.018]
HAN JiamingGAO ZhongshanMA Yulan.Inappropriate Sinus Tachycardia[J].Advances in Cardiovascular Diseases,2022,(4):253.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.018]
[6]聂琼 吴镜.射血分数保留性心力衰竭：从机制到治疗[J].心血管病学进展,2022,(3):258.[doi:【DOI】10.16806/j.cnki.issn.1004-3934.2022.03.0170]
NIE Qiong,WU Jing.Heart Failure with Preserved Ejection Fraction:from Mechanism to Treatment[J].Advances in Cardiovascular Diseases,2022,(4):258.[doi:【DOI】10.16806/j.cnki.issn.1004-3934.2022.03.0170]
[7]智慧 赵青 柳志红.慢性血栓栓塞性肺动脉高压发病机制新进展：从基础到临床[J].心血管病学进展,2022,(4):297.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.003]
HUANG Zhihua,LUO Qin,ZHAO Zhihui,et al.Pathogenesis of Chronic Thromboembolic Pulmonary Hypertension:from Bench to Bedside[J].Advances in Cardiovascular Diseases,2022,(4):297.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.003]
[8]丁晓彤 郭俊 王大震 朱胜松 杨斐然 唐闽.肾积水与高血压的研究进展[J].心血管病学进展,2023,(3):212.[doi:10.16806/j.cnki.issn.1004-3934.2023.03.005]
DING Xiaotong,GUO Jun,WANG Dazhen,et al.Hydronephrosis and Hypertension[J].Advances in Cardiovascular Diseases,2023,(4):212.[doi:10.16806/j.cnki.issn.1004-3934.2023.03.005]
[9]张丹 钟广伟 杨海燕 时拥月 秦钦 姚佳梅.左心室心肌致密化不全心肌病的研究进展[J].心血管病学进展,2023,(4):316.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.007]
ZHANG DanZHONG Guangwei,YANG Haiyan,SHI Yongyue,et al.Left Ventricular Noncompaction Cardiomyopathy[J].Advances in Cardiovascular Diseases,2023,(4):316.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.007]
[10]雷悦云 邵磊 高传玉 张优.早发冠心病发病机制相关基因多态性研究进展[J].心血管病学进展,2023,(4):331.[doi:10.16806/j.cnki.issn.1004-3934.2023.04.010]
LEI Yueyun,SHAO Lei,GAO Chuanyu,et al.Gene Polymorphisms related to the Pathogenesis of?remature Coronary Artery Disease[J].Advances in Cardiovascular Diseases,2023,(4):331.[doi:10.16806/j.cnki.issn.1004-3934.2023.04.010]